Every Cat Logo


W00-001: Bioactivity of Recombinant Feline Erythropoietin

Non-regenerative anemia, which is characterized by an inadequate production of new red blood cells, is a frequent and serious complication of kidney failure, certain forms of cancer or cancer therapy, and other chronic diseases. These investigators have developed a new synthesized form of feline erythropoietin, a red blood cell stimulating hormone. The human form of this hormone has been available for more than a decade, but is not safe to use in the cat. This study will assess the bioactivity of this new therapy in the laboratory and in cats with non-regenerative anemia.

Grant ID: W00-001

Status: Active

Year Funded: 2000

Amount awarded: $15,000

Investigator: James N. MacLeod, VMD, PhD, JF Randolph, DVM; Cornell University